Hawkshaw M

Strobovideolaryngoscopy: Results and Clinical Value

Strobovideolaryngoscopy is a valuable addition to the diagnostic armamentarium because it allows the otolaryngologist to perform a detailed physical examination of the vibratory margin of the vocal fold. From 1985 through 1989, we performed 1,876 strobovideolaryngoscopy procedures, the majority on professional voice users. Previously, we reported findings on our first 486 strobovideolaryngoscopy procedures. Stroboscopic information influenced diagnosis or treatment in approximately one third. The present study was undertaken to determine whether additional experience had altered the clinical usefulness of the procedure. Diagnoses were noted before and after stroboscopy prospectively for 377 strobovideolaryngoscopy procedures performed during the calendar year 1989. In 53% of the procedures, strobovideolaryngoscopy resulted in no change in diagnosis. In 29%, preprocedure impressions were confirmed and additional diagnoses were made. In 18%, preprocedure diagnoses were found to be incorrect. The procedure has proven very helpful in caring for voice patients, modifying diagnoses in 47%, and confirming uncertain diagnoses in many of the other patients studied.

The aging adult voice

Advancing age produces physiologic changes that may alter voice. Some of these changes are inevitable; others may be avoidable or reversible. In addition, many treatable medical conditions may cause voice changes similar to those of aging. It is essential that all voice care providers be familiar with the expected changes of aging, and be alert to reversible conditions that may adversely affect phonation and be mistaken for presbyphonia.

Autologous fat implantation for vocal fold scar: a preliminary report.

New insights into the anatomy and physiology of phonation, along with technological advances in voice assessment and quantification, have led to dramatic improvements in medical voice care. Techniques to prevent vocal fold scar have been among the most important, especially scarring and hoarseness associated with voice surgery. Nevertheless, dysphonia due to vocal fold scar is still encountered all too frequently. Although it is not generally possible to restore such injured voices to normal, patients with scar-induced dysphonia can usually be helped. Voice improvement is optimized through a team approach. Treatment may include sophisticated voice therapy and vocal fold surgery. Although experience with collagen injection has been encouraging in selected cases (particularly in those involving limited areas of vocal fold scar), there is no consistently successful surgical technique. Attempts to treat massive vocal fold scar, such as may be seen following vocal fold stripping, have been particularly unsuccessful. This paper reports preliminary experience with the implantation of autologous fat into the vibratory margin of the vocal fold of patients with severe, extensive scarring. Using this technique, it appears possible to recreate a mucosal wave and improve voice quality. Additional research is needed.

Chondrosarcoma of the Skull Base

Objectives Sarcomas of the skull base are challenging, potentially lethal tumors. Prognosis is considered poor. The present report reviews treatment options and presents a case of treatment with en bloc resection of the temporal bone and adjacent skull base.

Management of Vocal Fold Scar with Autologous Fat Implantation: Perceptual Results

Vocal fold scar disrupts the mucosal wave and interferes with glottic closure. Treatment involves a multidisciplinary approach that includes voice therapy, medical management, and sometimes surgery. We reviewed the records of the first eight patients who underwent autologous fat implantation for vocal fold scar. Information on the etiology of scar, physical findings, and prior interventions were collected. Videotapes of videostroboscopic findings and perceptual voice ratings [Grade, Roughness, Breathiness, Asthenia, Strain (GRBAS)] were randomized and analyzed independently by four blinded observers. Etiology of scar included mass excision (7), vocal fold stripping (3), congenital sulcus (2), and hemorrhage (1). Prior surgical procedures performed included thyroplasty (1), autologous fat injection (9), excision of scar (2), and lysis of adhesions (2). Strobovideolaryngoscopy: Statistically significant improvement was found in glottic closure, mucosal wave, and stiffness (P = 0.05). Perceptual ratings (GRBAS): Statistically significant improvement was found in all five parameters, including overall Grade, Roughness, Breathiness, Asthenia, and Strain (P = 0.05). Patients appear to have improved vocal fold function and quality of voice after autologous fat implantation in the vocal fold. Autologous fat implantation is an important adjunctive procedure in the management of vocal fold scar, and a useful addition to the armamentarium of the experienced phonomicrosurgeon.

Laryngeal Electromyography: Clinical Application

Laryngeal electromyography (LEMG) is a valuable adjunct in clinical management of patients with voice disorders. LEMG is valuable in differentiating vocal fold paresis/paralysis from cricoarytenoid joint fixation. Our data indicate that visual assessment alone is inadequate to diagnose neuromuscular dysfunction in the larynx and that diagnoses based on vocal dynamics assessment and strobovideolaryngoscopy are wrong in nearly one-third of cases, based on LEMG results. LEMG has also proven valuable in diagnosing neuromuscular dysfunction in some dysphonic patients with no obvious vocal fold movement abnormalities observed during strobovideolaryngoscopy. Review of 751 patients suggests that there is a correlation between the severity of paresis and treatment required to achieve satisfactory outcomes; that is, LEMG allows us to predict whether patients will probably require therapy alone or therapy combined with surgery. Additional evidence-based research should be encouraged to evaluate efficacy further.

Laryngeal myasthenia gravis: report of 40 cases.

Myasthenia gravis, an autoimmune disorder of the neuromuscular junction, is usually recognized because of ocular complaints or generalized weakness. We report a series of 40 patients who presented with dysphonia as their initial and primary complaint. Diagnostic testing included strobovideolaryngoscopy, electromyography (EMG) with repetitive stimulation and Tensilon testing, and laboratory and radiographic evaluation. Strobovideolaryngoscopy most commonly revealed fluctuating impairment of vocal fold mobility, either unilateral or bilateral. EMG detected evidence of neuromuscular junction abnormalities in all patients. Only one patient had evidence of antiacetylcholine receptor (ACh-R) antibodies, but many other abnormalities suggestive of autoimmune dysfunction were present. Pyridostigmine therapy was initiated in 34 patients but was not tolerated in 4. Of the remaining 30 patients, 23 reported improvement of symptoms. We conclude that myasthenia gravis can present with symptoms confined primarily to the larynx and should be included in the differential diagnosis of dysphonia.

Voice range in superior laryngealnerve paresis and paralysis

Evaluation of Physiologic Frequency Range (PFR) and Musical Frequency Range (MRP) of Phonation was performed on 56 adults (singers and nonsingers) presenting with superior laryngeal nerve (SLN) paresis or paralysis confirmed by laryngeal electromyography. The most common etiology was neuritis (69.7%), followed by iatrogenic and unknown causes,each accounting for 10.2% of cases, and finally trauma (8.9%). Both female and male singers with SLN paresis or paralysis had significantly higher PFR and MPR than nonsingers. Female classical singers presented PFR and MPR of up to 10 semitones (ST) higher than nonclassical singers and nonsingers. The lowest PFR and musical ranges were found in patients with SLN paresis associated with recurrent laryngeal nerve paresis or paralysis. The authors suggest that voice range measurement is a useful parameter for analyzing the effects of SLN paresis or paralysis on voice and that it may also assist in measuring outcome following voice therapy.

Respiratory function in singers: Medical assessment, diagnoses, and treatments

Summary A healthy voice depends upon healthy respiration. An understanding of respiratory function is essential in evaluating disorders that affect the voice. This review addresses the assessment of respiratory complaints by history, physical examination, laboratory testing, and endoscopic procedures. Allergy testing and pulmonary function testing are covered in detail. Special problems that confront the professional voice user, such as the need to optimize respiratory function even in mild disease states, exposure to environmental irritants, and the athletic demands of performance, are related specifically to respiratory function. The discussion of diagnosis and treatment of common ailments such as allergic rhinitis and bronchitis is directed toward treatment of the active singer.

Reliability of Objective Voice Measures of Normal Speaking Voices

OBJECTIVE To determine the reliability of objective voice measures used commonly in clinical practice. SUBJECTS Eighteen healthy volunteers (nine males and nine females). METHODS Objective voice measures were performed on 18 healthy volunteers on 10 occasions under similar conditions over a 30-day period. Consistency of measures was analyzed to determine reliability. RESULTS Using currently accepted normative values, intraclass correlation coefficients were moderate (>0.6) for consistency over the 10 testing sessions for most acoustic measures that do not depend on intensity, measures of laryngeal efficiency, and perturbation measures of fundamental frequency (F0) for both genders. For females, cepstral peak prominence (CPP) had moderate reliability, whereas for males, the smoothed CPP was reliable. Other than F0, none of the perturbation measures are reliable for females. However, jitter, relative average perturbation, and standard deviation of F0 are reliable for males. Noise-to-harmonic ratios (NHRs) had the lowest consistency of all measures over the course of the 10 sessions. CONCLUSIONS Clinicians should be cautious in their use of acoustic voice measures that depend on the intensity and in their use of most perturbation measures. NHR was found to be the least reliable measure. Additionally, the reliability of CPP measure varies by gender. Understanding the degree of within-person variability on some objective voice measures and whether that variation is due to biological differences or measurement error will lead clinicians to consider the need for a more standardized testing protocol. Additional research is needed to investigate what factors within the testing protocol and/or changes to the measurement instruments may lead to more consistent test results.